Castle Biosciences Inc (CSTL)

Aug 02, 2025

What catalysts could drive Castle Biosciences Inc. stock higher in 2025Invest smarter with expert trading signals - jammulinksnews.com

Aug 02, 2025

Aug 02, 2025

Should I hold or sell Castle Biosciences Inc. stock in 2025Market-leading capital gains - jammulinksnews.com

Aug 02, 2025

Aug 02, 2025

How many analysts rate Castle Biosciences Inc. as a “Buy”Free Stock Selection - jammulinksnews.com

Aug 02, 2025

Aug 02, 2025

Castle Biosciences Q2 Earnings Preview: Analysts Expect $-0.50 EPS - AInvest

Aug 02, 2025

Aug 01, 2025

Castle Biosciences CSTL Q2 2025 Earnings Preview Upside Potential on Raised Revenue Forecast - AInvest

Aug 01, 2025

Aug 01, 2025

Some Confidence Is Lacking In Castle Biosciences, Inc. (NASDAQ:CSTL) As Shares Slide 26% - 富途牛牛

Aug 01, 2025

Jul 29, 2025

Published on: 2025-07-30 02:23:31 - metal.it

Jul 29, 2025

Jul 29, 2025

The True Test of Success - thebossmagazine.com

Jul 29, 2025

Jul 29, 2025

Castle Biosciences to Present at the Canaccord Genuity 45th Annual Growth Conference - GlobeNewswire

Jul 29, 2025

Jul 29, 2025

Healthcare Innovator Castle Biosciences Reveals Latest Growth Strategy at Major Investment Conference - Stock Titan

Jul 29, 2025

Jul 28, 2025

What Technical Tools Say About Castle Biosciences Inc. RecoveryConsistent Income Focused Trade List Analyzed - metal.it

Jul 28, 2025

Jul 28, 2025

Earnings Preview: Castle Biosciences, Inc. (CSTL) Q2 Earnings Expected to Decline - Yahoo Finance

Jul 28, 2025

Jul 28, 2025

Castle Biosciences, Revolution Medicines get FDA breakthrough statuses - MSN

Jul 28, 2025

Jul 28, 2025

How volatile is Castle Biosciences Inc. stock compared to the marketBreakneck growth rates - jammulinksnews.com

Jul 28, 2025

Jul 28, 2025

When is Castle Biosciences Inc. stock expected to show significant growthFree Stock Insights For Every Investor - jammulinksnews.com

Jul 28, 2025

Jul 28, 2025

What is the dividend policy of Castle Biosciences Inc. stockExponential wealth increase - jammulinksnews.com

Jul 28, 2025

Jul 28, 2025

What are Castle Biosciences Inc. company’s key revenue driversInvest in stocks with strong fundamentals - jammulinksnews.com

Jul 28, 2025

Jul 27, 2025

How does Castle Biosciences Inc. generate profit in a changing economyBuild a portfolio that withstands market volatility - jammulinksnews.com

Jul 27, 2025

Jul 27, 2025

What is the risk reward ratio of investing in Castle Biosciences Inc. stockHigh-yield portfolio picks - jammulinksnews.com

Jul 27, 2025

Jul 27, 2025

Castle Biosciences (NASDAQ:CSTL) shareholders have endured a 58% loss from investing in the stock five years ago - Yahoo Finance

Jul 27, 2025

Jul 27, 2025

Is Castle Biosciences Inc. Stock Overbought or Oversold RSI Indicator AnalysisCapital Safe Smart Trades - Newser

Jul 27, 2025

Jul 27, 2025

Castle Biosciences Inc. Stock Performance After Earnings: Historical InsightsTop Gaining Low Risk Assets - Newser

Jul 27, 2025

Jul 27, 2025

Cerity Partners LLC Buys Shares of 21,138 Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

Jul 27, 2025

Jul 25, 2025

Castle Biosciences’ Founder, President and CEO Derek - GlobeNewswire

Jul 25, 2025

Jul 25, 2025

Castle Biosciences stock jumps after FDA grants Breakthrough Device status to melanoma test - MSN

Jul 25, 2025

Jul 25, 2025

Castle Biosciences’ Founder, President and CEO Derek Maetzold Named a Most Admired CEO by the Houston Business Journal - Santé log

Jul 25, 2025

Jul 25, 2025

Why Castle Biosciences Inc. stock is on top investor watchlistsSkyrocketing returns - jammulinksnews.com

Jul 25, 2025

Jul 25, 2025

Castle Biosciences' Founder, President and CEO Derek Maetzold Na - News Channel Nebraska Southeast

Jul 25, 2025

Jul 25, 2025

Castle Biosciences shares rise 1.40% premarket after FDA grants Breakthrough Device Designation to DecisionDx-Melanoma test. - AInvest

Jul 25, 2025

Jul 25, 2025

Castle Biosciences Inc. Stock Analysis and ForecastRapid profit acceleration - PrintWeekIndia

Jul 25, 2025

Jul 24, 2025

Leerink Partnrs Has Pessimistic View of CSTL Q2 Earnings - Defense World

Jul 24, 2025

Jul 24, 2025

Castle Biosciences stock jumps after FDA grants Breakthrough Device status - Investing.com

Jul 24, 2025

Jul 23, 2025

What drives Castle Biosciences Inc. stock priceRapidly expanding wealth - Autocar Professional

Jul 23, 2025

Jul 23, 2025

What analysts say about Castle Biosciences Inc. stockSkyrocketing investment returns - Autocar Professional

Jul 23, 2025

Jul 23, 2025

Castle Biosciences stock jumps after FDA grants Breakthrough Device status By Investing.com - Investing.com India

Jul 23, 2025

Jul 23, 2025

FDA Grants Breakthrough Status to Melanoma Test - Conexiant

Jul 23, 2025

Jul 23, 2025

FDA grants breakthrough device status to Castle Biosciences’ melanoma test - Investing.com

Jul 23, 2025

Jul 23, 2025

FDA Grants Breakthrough Device Designation to Castle Biosciences’ DecisionDx®-Melanoma Test - GlobeNewswire

Jul 23, 2025

Jul 23, 2025

FDA Breakthrough: Castle Biosciences' New Melanoma Test Could Transform Cancer Diagnosis - Stock Titan

Jul 23, 2025

Jul 23, 2025

New York State Common Retirement Fund Has $3.27 Million Stock Position in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

Jul 23, 2025

Jul 23, 2025

Castle Biosciences shares rise 4.35% premarket after FDA grants Breakthrough Device Designation to DecisionDx-Melanoma test. - AInvest

Jul 23, 2025

Jul 22, 2025

Is Castle Biosciences Inc. a good long term investmentHigh-margin investment plays - jammulinksnews.com

Jul 22, 2025